Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia. Mazzitelli M, Arrighi E, Serapide F, Pelle MC, et al. J Med Virol 2020 May 15. doi: 10.1002/jmv.26016.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mazzitelli M, Arrighi E, Serapide F, Pelle MC, et al. Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia. J Med Virol 2020 May 15. doi: 10.1002/jmv.26016.
PMID: 32410234